Picture of Vitrolife AB logo

VITR Vitrolife AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line493366460537-3,712
Depreciation
Non-Cash Items96.47.71-30.8804,376
Unusual Items
Other Non-Cash Items
Changes in Working Capital-176-102-154-377-332
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities413356384636757
Capital Expenditures-87.1-20.1-62.4-87-119
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-25.5-0.132-6,456-57-5
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-113-20.2-6,518-144-124
Financing Cash Flow Items-10.8-337-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-107-26.65,749-582-300
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash199284-343-51283